<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Certain Gabapentin Immunoassay Kits and Test Strips, Components Thereof, and Methods Therefor; Commission Determination Not To Review an Initial Determination Terminating a Final Respondent Based on Settlement; Request for Written Submissions on Remedy, the Public Interest, and Bonding</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Certain Gabapentin Immunoassay Kits and Test Strips, Components Thereof, and Methods Therefor; Commission Determination Not To Review an Initial Determination Terminating a Final Respondent Based on Settlement; Request for Written Submissions on Remedy, the Public Interest, and Bonding</h1>
    <p class="timestamp">Published: 2022-02-28 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination ("ID") (Order No. 29) terminating the final, non-defaulting respondent, Shanghai Chemtron Biotech Co. Ltd., in the above-captioned investigation based on settlement. The Commission has further determined to find that the complainants' declaration seeking immediate relief against a respondent previously found to be in default is moot. The Commission also requests written submi...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> International Trade Commission</p>
    <p><strong>Document Number:</strong> 2022-04080</p>
    <p><strong>Publication Date:</strong> 2022-02-28</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/02/28/2022-04080/certain-gabapentin-immunoassay-kits-and-test-strips-components-thereof-and-methods-therefor">https://www.federalregister.gov/documents/2022/02/28/2022-04080/certain-gabapentin-immunoassay-kits-and-test-strips-components-thereof-and-methods-therefor</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-04080</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
